Skip to content
healthcare.dev

glycopyrrolate

NDC 71839-125, glycopyrrolate, injection, from BE Pharmaceuticals Inc..

Product NDC
71839-125
Status
Listed
Labeler
BE Pharmaceuticals Inc.
Dosage form
INJECTION
Route
INTRAMUSCULAR, INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211705
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71839-125 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCOPYRROLATE1 mg/5mL

Pharmacologic classes

Anticholinergic [EPC]; Cholinergic Antagonists [MoA]

Package NDCNDC-11Package
71839-125-257183901252525 VIAL, MULTI-DOSE in 1 CARTON (71839-125-25) / 5 mL in 1 VIAL, MULTI-DOSE (71839-125-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d9df3900-a8c2-438b-8971-ba11ff91f90b
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71839-125

Use it

Look up 71839-125 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71839-125 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71839-125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.